Evaluation of Anti-arthritic and Analgesic Activity of Celastruspaniculatus in Different Animal Models doi.org/10.26538/tjnpr/v5i8.15

Main Article Content

Nishat Fatima
Sharoor Begum
Michael K. Neckola

Abstract

The goal of the management of arthritis is to alleviate pain, joint swelling and inflammations. Most commonly prescribed nonsteroidal anti-inflammatory agents (NSAIDs) have associated side effects on human health. The search for a novel agent is therefore essential. The study evaluated the anti-arthritic and analgesic activity of Celastruspaniculatusethanol extract in animal models. Arthritis was induced using formalin (0.1 mL 2% v/v), while hyperalgesia by acetic acid and eddy‘s hot plate in Wistar rats. The extracts, at 250 mg/kg and 500 mg/kg was administered to the animals for ten days. Changes in paw thickness, paw oedema volume and C-reactive protein levels were recorded. Histopathological analysis of knee joint was performed. The study results revealed that the extracts of Celastruspaniculatussignificantly (p˂ 0.05) inhibited the increase in parameters of arthritis, inflammation and pain in a dose-dependent manner (the maximum effect was observed in 500 mg/kg body weight) and restored the normal architecture of the knee joint tissues. The study confirms the anti-arthritic and analgesic activity of Celastruspaniculatus

Article Details

How to Cite
Fatima, N., Begum, S., & K. Neckola, M. (2021). Evaluation of Anti-arthritic and Analgesic Activity of Celastruspaniculatus in Different Animal Models: doi.org/10.26538/tjnpr/v5i8.15. Tropical Journal of Natural Product Research (TJNPR), 5(8), 1414-1421. https://tjnpr.org/index.php/home/article/view/465
Section
Articles

References

Harris ED. Rheumatoid arthritis; pathophysiology and implications for therapy. N Engl J Med. 1990; 322(18): 1277-1289.

Calixto JB. Efficacy safety quality control marketing and regulatory guideline for herbal medicines (phytotherapetic agent). Braz J Med Biol Res. 2000; 33(2):179-189.

Mohsen Y, Akshay K, Bhaskaran. Phyto-pharmacology ofCelastruspaniculatus. An overview. International journal of chemistry and applications. 2013; 5(3):223-235.

Gabriel SE. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001; 27(2):269–81.

Symmons DP, Barrett EM, Bankhead CR, Scott, DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol. 1994; 33(8):735-739.

NCCCC (National Collaborating Centre for Chronic Conditions). Rheumatoid arthritis: National clinical guideline for management and treatment in adults. London: Royal College of Physicians (UK); 2009. 275 p.

Silman AJ and Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002; 4(3):S265-272.

Qiang G, Wang Y, Xu D, Nossent J, Nathan J, PavlosXu. J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018; 6 (15): 1-14.

Altawil R, Saevarsdottir S, Wedrén S, Alfredsson L, Klareskog L, Lampa J, ―Remaining Pain in Early Rheumatoid Arthritis Patients Treated with Methotrexate.‖ Arthritis Care Res. 2016; 68(8): 1061-1068.

McWilliams DF and Walsh DA. Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: Results from the British society for rheumatology biologics register,‖ BMC Musculoskelet. Disord. 2016; 12(17):337.

Lee YC, Nassikas, NJ, Clauw DJ. The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res Ther. 2011; 13(2):211.

Huskisson EC and Hart FD. Pain threshold and arthritis. Br Med J. 1972; 4(5834):193-195.

Gerecz-Simon EM, Tunks ER, Heale JA, Kean WF, Buchanan WW. Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls. ClinRheumatol. 1989; 8(4):467-474.

Dwivedi V and Maurya H.A Comprehensive Overview of CelastruspaniculatusSeed Oil Intended for the Management of Human Ailments. Indian J. Pharm. Biol. Res. 2018; 6(2):37-42

Palle S, Kanakalatha A, Kavitha CN. Gastroprotective and Antiulcer Effects of Celastruspaniculatus Seed Oil against Several Gastric Ulcer Models in Rats. J Diet Suppl. 2018; 15(4):373-385.

John SB, Mani B, Thomas S, Prabhu S. A new subspecies of Celastrus (Celastraceae) from the Palni hills of South India. Taiwania. 2017; 62(3):311-314.

Dhiman AK. Conservation of some useful medicinal plants of Haridwar district in Uttaranchal state.In: Chopra AK, Khanna DR, Prasad G, Malik DS, Bhutiani R (ed.) Medicinal plants: Conserv Cult Util. 2007; 147-166.

Nath V and Khatri PK. Traditional knowledge on ethnomedicinal uses prevailing in tribal pockets of Chhindwara and Betul districts, M.P, India. Afr J Pharm Pharmacol. 2010; 4(9):662-670.

Panda H. Handbook on Herbal drugs and its plant Sources. NIIR publications. Delhi. 1994. 44-45 p.

Kamalinee AD and Nanda WS. Celastruspaniculatus; medicinal and pharmacological properties: A Review. Int J DevRes..2015; 5(9):5526-5531.

Singh H, Krishna G, Baske PK. Plants used in the treatment of joint diseases (rheumatism, arthritis, gout, lumbago) in Mayurbhunj district of Odisha, India. Rep Bot Surv India 2010; 2(9):22-26.

Sudaroli M and Chatterjee TK. Evaluation of red and white seed extracts of Abrusprecatorius Linn., against Freund‘s complete adjuvant induced arthritis in rats. J Med Plants Res. 2007; 1(4):86-94.

Khandelwal KR, Kokate CK, Gokhale SR. Practical Pharmacognosy Techniques and experiments.NiraliPrakashan, Pune. 1996. 104-106 p.24. Chinnasamy V, Subramaniyan V, ChandiranS, Kayarohanam S, Chidambaram DK, Venkata SSV, Muhammad S. Anti-arthritic Activity

of AchyranthesAspera on formaldehyde - induced arthritis in rats. Maced J Med Sci. 2019; 7(17):2709-2714.

Godkar PB, Gordon RK, Ravindran A, Doctor BP. Celastruspaniculatus seed oil and organic extracts attenuate hydrogen peroxide- and glutamate-induced injury in embryonic rat forebrain neuronal cells. Phytomed. 2006; 13(1-2):29-36.

Mangesh BS, Virendra KG, Ashwin SD. Evaluation of analgesics and anti-inflammatory activity of a poly-herbal formulation. Int J Pharm Tech Res. 2010; 2(2):1520-1527.

Lohit BB, Ghosh P, Gaur V, Bodhankar SL. Effect of petroleum ether extract of SphaeranthusindicusLinn. on complete freunds adjuvant induced arthritis in laboratory rats. Pharmacol Online. 2009; 2:281-291.

Sachin V, Subhash BL, Vishwaraman M, Prasad TA. Anti-inflammatory and anti-arthritic activity of type-A procyanidine polyphenols from bark of Cinnamomumzeylanicumin rats. Food Sci Hum Wellness. 2013; 2(2):59-67.

Sun K, Song X, Yong RJ, Yin Z , Zou Y, Li L, Yin L, Changliang H, Liang X, Yue G, Cui Q,YangY. Evaluation of analgesic and anti-inflammatory activities of extracts of Gallachinensisin vivo model. J Evid-Based ComplAltern Med.2018;( 6784032):1-7.

Borrelli F, Borboneb N, Capassoa R, Montesanoc D, Marinob S, Aviello G, Aprea G, StefaniaM,AngeloAI.Potent relaxant effect of

a Celastruspaniculatus extract in the rat and human ileum. J Ethnopharmacol. 2009; 122(3):434-438.

Nalini K, Karanth KS, Rao A, Aroor AR, Effects of Celastruspaniculatus on passive avoidance performance and biogenic amine turnover in albino rats. J Ethnopharmacol. 1995; 47(2):101-108.

Gaitonde BB, Raiker KP, Shroff FN, Patel JR. Pharmacological studies with Malakanguni, an indigenous tranquillizing drug (Preliminary report). Curr Med Prac. 1957; 1:619-621.

Shroff FN, Gaitonde BB, Patel JR. Tranquillizers (An experimental study). J Group Hosp. 1959; 4: 160-173.

Kalpana SP and Jayaprakash S. Effect of CelastruspaniculatusWilld. seed on adjuvant induced arthritis in Rats. Phcog Mag. 2007; 3(11):177-181.

Marius M, Jabeen A, Shabana SU, Nida D, Aisha F. Antiarthritic property of crude extracts ofPiptadeniastrumafricanum Mimosaceae) in complete Freund‘s adjuvant-induced arthritis in rats. BMC Comp Altern Med. 2017; 17(1):111.

Macfarlane E, Markus JS, Zhou H. Arthritis and role of endogenous glucocorticoids. Bone Res. 2020; 8(33):1-17.

Zanten VA, Arend S, Roozendaal C, Limburg PC, Maas F, Trouw LA, Toes REM, Huzinga TWJ. Bootsma H, Brouwer E. Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands. Ann Rheum Dis. 2017; 76(7):1184-1190.

Peter CH, Ibrahim MR, Alebreheem M, Lawrence AP.Creactive protein and cancer-Diagnostic and therapeutic insights. Front Immunol. 2020; 11(595835):1-34.

Shiva S, Declan W,Nowacki SA , Lorton C4 , Aktas A, Hullihen B, Nabila BB, Katherine H, Serkan A , Bassam E. Serum C-reactive protein is an important and powerful prognostic marker in most adult solid tumors. PLoS ONE. 2018; 13(8):e0202555:1-12.

Kilcher G, Hummel N, Didden ME, EggerM, Reichenbach S. Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries. Rheumatol. 2018; 57(2):354-369.

Masi AT, Aldag JC, Sipes J. Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: correlations with pre-RA status and baseline positive rheumatoid factors. J Rheumatol.2001; 28(10):2359-2361.

Sproston NR and Ashworth JJ.Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;13(9):754.

Nishat F and Jabeen SF. Pharmacological screening for anti-arthritic activity of Moringa oleifera. Asian J Pharm Clin Res. 2016;9(3):106-111.

Heiberg T, Finset A, Uhlig T, Kvien TK. Seven-year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis.2005; 64(2):191–195.

Klooster TPM, Veehof MM, Taal E, Van RPL, Van D L MA. Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment. Ann Rheum Dis. 2007; 66(11):1485–1490.

Borenstein D, Altman R, Bello A, Chatham W, Clauw DJ, Crofford LJ, et al. Report of the American college of rheumatology pain management task force. Arthritis Care Res. 2010; 62(5):590–599.

Fausto Si, Giovanni G, Marco DCGF, Ralph B, Sherine EG, Iain BM. Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets—A Focus on the JAK-STAT Pathway.Pain Res Manag. 2018; (8564215):1-14.

Rausch OAK,Niedermann K, Braun J, Adams J, Brodin N, Dagfinrud H, Duruoz T, Esbensen BA, Günther KP, Hurkmans E, Juhl CB, Kennedy N, Kiltz U, Knittle K, Nurmohamed M, Pais S, Severijns G, Swinnen TW, Pitsillidou IA, Warburton L, Yankov Z, VlietVlieland

TPM.EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018; 77(6):797-807.

Zhi YY, Lu L, Shuai SC, Qing S, Zheng L M, XaoPG.Anti-nociceptive effects of dihydrocorydaline in mouse models of inflammatory pain involved in opioid receptor and inflammatory cytokines. Sci Rep. 2016:6 (27129):1-8.

Yongwoo J, Minseok K, Sun WH. Molecular mechanisms underlying the actions of arachidonic acid.J Neuroinflam. 2020; 17(30):1-27.

Basu NK and Pabrai PR. A chemical investigation of Celastruspaniculata wild. J Am Pharm Assoc. 1946; 35(9): 272-273.

Shashank D, Rajendra SV, Anamika M. An overview of Phytoconstituents and pharmacological activities ofCelastruspaniculatus. J Pharm Res. 2017; 16(4):307.

Patil P, Soujanya B, Kiran K A. A review on Lupeol: Superficial triterpenoid from horticulture crops.Int J Chem Stud. 2018; 6(3):3301-3305.

Monojit D, Moulisha B, Vinay JS, Nishteswar K. Phytochemical and analytical evaluation of Jyotishmati (Celastrus paniculatus Wild.) leaf extracts. Ayuv. 2014; 35(1):54-57.

Ahmad F, Khan RA, Rasheed S. Preliminary screening of methanol extracts of Celastruspaniculatus and Tecomellaundulata for

analgesic and anti-inflammatory activities. J Ethnopharmacol. 1994; 42(3):193-198.

Parcha V, Gahlot M, Tomar Y, Ram V. Studies on physicchemical properties, anti-inflammatory and antimicrobial activity of Celastruspaniculatusseed oil. Indian J Nat Prod. 2003; 19(2):21-22.